https://www.selleckchem.com/pr....oducts/remdesivir.ht
0001), history of major bleeding (OR 2.85; 95% CI, 1.96-4.14; P less then .0001), time since AF diagnosis (OR 1.04; 95% CI, 1.01-1.06; P less then .0001), concomitant vascular disease (OR 1.43; 95% CI, 1.10-1.87; P = .0008) and diabetes mellitus (OR 1.3; 95% CI, 1.02-1.65, P = .03). Patients with minor bleeding, compared with the remaining subjects scored higher on the JAKQ (median, 62.5% vs 56.2%, respectively, P less then .0001). The former group knew more about the purpose of anticoagulant therapy (71.8% vs 65.7%, P = .01) and ble
Like
Comment
Share
